πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7465716

Targeted drug delivery with a hyaluronan ligand

The Regents of the University of California Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7442696

Mineralocorticoid receptor modulator compounds, processes for their preparation, and their

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7439027

Method for modulating process mediated by farnesoid activated receptors

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7435801

Antibodies and other ligands directed against KIR2DL4 receptor for production of interfero

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7435733

Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical composition

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371392

Cd40 ligand adjuvant for respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368100

Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and me

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7348359

Retinoid X receptor modulators

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332298

Nucleic acids encoding multimeric proteins of TNF superfamily ligands

The Regents of the University of California Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7329651

Cannabimimetic ligands

UNIVERSITY OF CONNECTICUT Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314887

Thrombopoietin activity modulating compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7309483

Method of treatment using Tie2 ligand2

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7300774

Multimeric fusion proteins of the TNF superfamily ligands

The Regents of the University of California Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7288258

Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and thei

Peptide Immune Ligands Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7268212

Ligand of G protein-coupled receptor protein and DNA thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7259278

Anti-S-phase tubulin ligands

Cytoskeleton, Inc. Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7241783

Thrombopoietin mimetics

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7214690

Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and me

Ligand Pharmaceuticals Incorporated Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7202040

Method for screening compounds which change the binding properties of a protein with a lig

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7192982

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7163935

Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7163946

5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7144986

Polypeptides comprising IL-6 ligand binding receptor domains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7128904

Material containing metal ion ligand complex producing nitric oxide in contact with blood

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted